Call for Abstract

28th International Conference on Cancer Research and Anticancer Therapies, will be organized around the theme “Furtherance and Innovations in Cancer Care”

Cancer Congress 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cancer Congress 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Cancer is a diseased condition created by out-of-control cell growth in a specific part of body. The abnormally grown cancerous cells can invade and damage surrounding healthy tissue and other organs as well. Cancer exists in different types and each one is characterized according to the type of cell that is initially affected. Cancer harms the body when altered cells divide in a uncontrolled manner and form masses of tissue which are called tumors. Cancerous tumors called malignant i.e. they can easily effect nearby tissues. Tumors that do not spread and have limited growth are generally considered to be benign. Most common symptoms of cancer include bleeding, prolonged cough, heavy weight loss, unusual lumps and change in bowel movements. With advancement in technology various types of cancers are curable if detected in earlier stages.

Cell biology of cancerous cells describes the underlying principles and mechanisms involved in evolvement of cancerous cells. It explains a clear description between a normal cell and cancerous cell to study progression and development of cancer cells. This study also helps study insights that could lead to the development of new clinical interventions. New data techniques have involved give a clear description of cell proliferation, signalling pathways and cell death.

  • Track 2-1Cancer Cell signalling
  • Track 2-2Cell Cycle Control
  • Track 2-3Chromosome Maintance
  • Track 2-4Molecules Related to Cancer

Cancer type is always categorized on the basis of initial location of occurrence of cancer. Accordingly there exist numerous types of organ cancer. The most common types of organ cancer is the prostate cancer and breast cancer. Bone cancer occurs very rarely whereas now   days gastrointestinal cancer has also effected a huge amount of population. Another growing cancer is the ovarian and colorectal cancer. The pharmaceutical industries dealing with breast cancer drugs have inclined in the recent years.

  • Track 3-1Prostrate cancer
  • Track 3-2Bladder cancer
  • Track 3-3Bile Duct cancer
  • Track 3-4Gastrointestinal cancer
  • Track 3-5Brain cancer
  • Track 3-6Pancreatic cancer
  • Track 3-7Liver Cancer
  • Track 3-8Cervical cancer
  • Track 3-9Head and neck cancer
  • Track 3-10Breast & ovarian cancer
  • Track 3-11Oesophagal cancer
  • Track 3-12Colorectal cancer
  • Track 3-13 Bronchial cancer

Leukemia is a cancer of the blood cells. Mostly, leukemia is cancer of WBCs. WBCs helps to  protect our body from invasion of bacteria, viruses, and fungi, as well as from abnormal cells and other foreign substances. In leukemia, WBCs divide too quickly and eventually crowd out normal cells.

They are mostly produced in the bone marrow and when formed, WBCs circulate throughout your body in your blood and lymph (fluid that circulates through the lymphatic system), concentrating in the lymph nodes and spleen.

  • Track 4-1Acute leukemia
  • Track 4-2Chronic leukemia
  • Track 4-3Lymphocytic leukemias
  • Track 4-4Myelogenous leukemias
  • Track 4-5Adult T-cell leukemia
  • Track 4-6Clonal eosinophilias
  • Track 4-7Signs & symptoms
  • Track 4-8Causes
  • Track 4-9Diagnosis &Treatment

Lymphoma is generally group of blood cancers that generate in the lymphatic system. The two main types of lymphoma are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Hodgkin lymphoma is different from  other lymphoma diseases like Reed-Sternberg cells disease which are kind of cancerous cells found in Hodgkin lymphoma tissues. Hodgkin lymphoma is one of the most curable forms of cancer.

  • Track 5-1Lymphadenopathy
  • Track 5-2High-grade lymphomas
  • Track 5-3Low-grade lymphomas
  • Track 5-4Immunodeficiency-associated lymphoproliferative disorders
  • Track 5-5Non-Hodgkin lymphomas
  • Track 5-6Hodgkin lymphoma
  • Track 5-7Fluorescence in situ hybridization
  • Track 5-8Flow cytometry
  • Track 5-9Immunophenotyping
  • Track 5-10Palliative care
  • Track 6-1Immunosurveillance
  • Track 6-2Molecular basis of immune receptor
  • Track 6-3Leukocyte Immunoglobulin-like Receptors

Cancer genomics characterizes the  cancer-associated genes. It mainly puts light on genetic, epigenomic and transcriptomic alterations in Cancer. Cancer is a genetic disease caused by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The aim of cancer genomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies.

  • Track 7-1Cancer genome atlas
  • Track 7-2 Epigenetic Silencing of Tumor cells
  • Track 7-3Molecular basis of clinical phenotypes
  • Track 7-4Gene mutation
  • Track 8-1Screening mammography
  • Track 8-2Sigmoidoscopy
  • Track 9-1Gene therapy
  • Track 9-2Radiation Therapy
  • Track 9-3Chemotherapy
  • Track 9-4Stem Cell Transplant
  • Track 9-5 Precision Medicine
  • Track 10-1Diagnosis
  • Track 10-2Prognosis
  • Track 10-3 PR/ER
  • Track 10-4 Pharmacodynamics and pharmacokinetics
  • Track 11-1Use of Erythopoeitin
  • Track 11-2 Anemia Management
  • Track 12-1Immune checkpoint inhibitors
  • Track 12-2Vaccines
  • Track 12-3Immuno therapy Vaccines
  • Track 12-4Oncolytic virus therapy
  • Track 12-5Adoptive T-cell therapy
  • Track 12-6 Cytokine therapy
  • Track 12-7 Sipuleucel-T
  • Track 12-8Dendritic cell therapy
  • Track 13-1Metastases
  • Track 13-2Metastatic illness
  • Track 14-1Anticancer Therapeutics
  • Track 14-2Clinical Trials
  • Track 14-3 Tumour Targeting Strategies
  • Track 14-4Oncological pharmacotherapy
  • Track 14-5Drug development
  • Track 15-1Carcinogenic bacteria
  • Track 15-2Salmonella typhi causing gall-bladder cancer
  • Track 15-3Helicobacter pylor causing gastric cancer
  • Track 15-4Gut Bacteria and Cancer Drug
  • Track 16-1Targeted drug therapies
  • Track 16-2 Molecular Profiling Techniques
  • Track 16-3 Chemical Proteomics
  • Track 16-4 Biologics & Vaccines
  • Track 16-5Clinical Trials
  • Track 16-6Novel Biomarker Discovery
  • Track 16-7Combination Strategies in Immuno-oncology
  • Track 16-8 Radiography
  • Track 17-1MRI Magnetic Resonance Imaging
  • Track 17-2 Echocardiography Tactile imaging
  • Track 17-3Magnetic Particle Imaging
  • Track 17-4 Tomography
  • Track 17-5Elastography
  • Track 17-6GIMIAS
  • Track 17-7 SPM
  • Track 17-8OsiriX
  • Track 18-1MRI Magnetic Resonance Imaging
  • Track 18-2 Diagnostic Radiology
  • Track 18-3 Helical Computed Tomography
  • Track 18-4 Angiography
  • Track 18-5 Positron emission tomography
  • Track 18-6Tomography
  • Track 19-1ITK-Snap
  • Track 19-2 3D Slicer
  • Track 20-1 Insertional Mutagenesis
  • Track 20-2DNA Repair
  • Track 20-3Site specific mutagenesis
  • Track 20-4 Prostrate Carcinogenesis
  • Track 20-5Radiation carcinogenesis
  • Track 20-6Hormonal carcinogenesis
  • Track 21-1Antipsychotic agents
  • Track 21-2Hydrogels
  • Track 21-3Immunosensors Biomedical Imaging